Evidence map›Paper›PMID 34683849›Full record

ArticlePharmaceutics2021

Quantifying Cytosolic Cytochrome c Concentration Using Carbon Quantum Dots as a Powerful Method for Apoptosis Detection.

Cristian Silviu Moldovan, Anca Onaciu, Valentin Toma, Radu Marginean, Alin Moldovan, Adrian Bogdan Tigu, Gabriela Fabiola Stiufiuc, Constantin Mihai Lucaciu, Rares Ionut Stiufiuc

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Cristian Silviu MoldovanDepartment of Pharmaceutical Physics & Biophysics, Faculty of Pharmacy, "Iuliu Hatieganu" University of Medicine and Pharmacy, Louis Pasteur Street No. 4-6, 400349 Cluj-Napoca, Romania.ORCID 0000-0003-2927-4622
Anca OnaciuDepartment of Pharmaceutical Physics & Biophysics, Faculty of Pharmacy, "Iuliu Hatieganu" University of Medicine and Pharmacy, Louis Pasteur Street No. 4-6, 400349 Cluj-Napoca, Romania.
Valentin TomaMedfuture-Research Center for Advanced Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, Marinescu 23/Louis Pasteur Street No. 4-6, 400337 Cluj-Napoca, Romania.
Radu MargineanMedfuture-Research Center for Advanced Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, Marinescu 23/Louis Pasteur Street No. 4-6, 400337 Cluj-Napoca, Romania.
Alin MoldovanMedfuture-Research Center for Advanced Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, Marinescu 23/Louis Pasteur Street No. 4-6, 400337 Cluj-Napoca, Romania.
Adrian Bogdan TiguMedfuture-Research Center for Advanced Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, Marinescu 23/Louis Pasteur Street No. 4-6, 400337 Cluj-Napoca, Romania.ORCID 0000-0001-9397-0791
Gabriela Fabiola StiufiucFaculty of Physics, "Babes Bolyai" University, Mihail Kogalniceanu Street No. 1, 400084 Cluj-Napoca, Romania.
Constantin Mihai LucaciuDepartment of Pharmaceutical Physics & Biophysics, Faculty of Pharmacy, "Iuliu Hatieganu" University of Medicine and Pharmacy, Louis Pasteur Street No. 4-6, 400349 Cluj-Napoca, Romania.ORCID 0000-0002-9385-3568
Rares Ionut StiufiucDepartment of Pharmaceutical Physics & Biophysics, Faculty of Pharmacy, "Iuliu Hatieganu" University of Medicine and Pharmacy, Louis Pasteur Street No. 4-6, 400349 Cluj-Napoca, Romania.ORCID 0000-0001-6769-1545
Iuliu Hațieganu University of Medicine and Pharmacy · ROBabeș-Bolyai University · RO

Funding

"Iuliu Hațieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania 1529/46 PCDUnitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii PN-III-P4-ID-PCCF-2016-0112
6 · The paper itself

Abstract

backgroundCytochrome c (Cyt c) is a key biomarker for early apoptosis, and many methods were designed to detect its release from mitochondria. For a proper evaluation of these programed cell death mechanisms, fluorescent nanoparticles are excellent candidates due to their valuable optical properties. Among all classes of nanoparticles developed thus far, carbon-based quantum dots bring qualitative and efficient imaging strategies for biomedical applications as a consequence of their biocompatibility and low cytotoxicity.

methodsIn this study, we synthesized carbon quantum dots smaller than 5 nm from sodium citrate and polyethylene imine. These nanoparticles were rigorously characterized, and their quenching capacity in apoptotic events was assessed in A549 cells treated with staurosporine and etoposide. For the evaluation of Cyt c release, a phenomenon directly correlated with apoptotic events, we ran a semiquantitative analysis using confocal laser scanning microscopy.

resultsCarbon quantum dots were synthesized and were successfully employed for Cyt c detection by means of fluorescence microscopy. Significant drops in fluorescence intensity were observed in the case of cells treated with apoptosis-inducing therapeutic compounds compared to untreated cells, confirming Cyt c release from mitochondria to cytosol.

conclusionConsidering these results, we strongly believe this method can contribute to an indirect in vitro evaluation of apoptosis.

Indexed as

apoptosiscarbon dotscellscytochrome cfluorescence

Identifiers

PMID34683849
PMCPMC8537359
OpenAlexW3204674577

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.